[1] ROBERT G P,STRICKLE Y,QUYNH I,et al.Pediatric drugs—A review of commercially available oral formulations.J Pharm Sci,2008,97(5): 1731-1774.[2] MILAP C N.Lack of pediatric drug formulations.Pediatrics,1999,104(3):606-610.[3] SHONN Y.Evaluation of consistency in dosing directions and measuring devices for pediatric nonprescription liquid medications.JAMA,2010,23(304):2595-2601.[4] ANNE M,WASIM B,JUNE H N.Are sugars-free medicines more erosive than sugars-containing medicines.An in vitro study of pediatric medicines with prolonged oral clearance used regularly and long-term by children.International J Pediatric Dentistry,2007,17(4): 231-238.[5] ZHANG L L,ZHANG C,LIANG Y,et al.A Comparative Study between the 2009 Edition National Essential Medicine List (Part of Primary Care )of China and WHO Model List of Essential Medicines for Children Update in 2010.Chin J Evid Base Med(中国循证医学杂志),2010,10(9): 1027-1036.[6] KITA F.Prescription trends for treatment of pediatric gastroenteritis at a Japanese hospital between 1997 and 2007.J Clinical Pharm Therap,2010,35(1):87-92.[7] NICOLE B,CARSTEN R.Quality of evidence-based pediatric guidelines.Pediatrics,2005,115(2):1378.[8] THORETEN T M,SIMONA S F,GIULIA G,et al.Three years of pediatric regulation in the European Union.Eur J Clin Pharmacol,2011,67(3):245-252.[9] OLSSON J,KIMAND E,PETTERSSON S,et al.Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care-A nationwide study.Acta Paediatrica,2011,100(9): 1272-1275. UFER M,KIMLAND E,BERGMAN U.Adverse drug reactions and off-label prescribing for paediatric outpatients: A one-year survey of spontaneous reports in Sweden.Pharmaco Drug Safety,2004,13(3): 147-152. UFER M,RANE M,KARLSSON A,et al.Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.Eur J Clin Pharmacol,2003,58(11): 779-783. LINDKVIST J,AIRAKSIN M,KAUKONEN A,et al.Evolution of paediatric off-label use after new significant medicines become available for adults: A study on triptans in Finnish children 1994-2007. Bri J Clin Pharml,2010,71(6):929-935. LINDELL O L,KORHONEN M J,SAANO S,et et.Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.J Clin Pharm Ther,2009,34(3): 277-287. BERG H,TAK N.Licensing and labelling of drugs in a paediatric oncology ward.Brit J Clin Pharmacol,2011,72(3): 474-481. STURKENBOOM M,FELISI M,MANFREDI C,et al.Paediatric status and off-label use of drugs in children in Italy,United Kingdom and the Netherlands.Pharm Pol Law,2009,11(1-2): 51-59. JONG G W,LINDEN P D,BAKKER E M,et al.Unlicensed and of-label drug use in a paediatric ward of a general hospital in the Netherlands.Eur J Clin Pharm,2002,58(4): 293-297. ZHANG L L,LI Y P,LIANG Y,et al.Off-iabel drug use in hospitalized children: A systematic review.Chin J Evid Base Med (中国循证医学杂志),2012,12(2): 176-187. CUSTOVIC A,SIMONS F E.Drugs used in paediatric allergy: Should we conduct studies in children or extrapolate from adults .Clin Exper All Rev,2006,36(9): 1-5. JOSEPH T.Ethics of placebo use in pediatric clinical trials: The case of antihypertensive drug studies.Hyper,2003,42(5):865-869. KLAUS R.Ethical,regulatory and scientific challenges in paediatric drug development.Pharm Med,2008,22(4):221-234. TERRY B,DAVID P,LUIGI G,et al.Developing paediatric medicines: Identifying the needs and recognizing the challenges.J Pharm Pharmacol,2007,59(8):1043-1055. ANTIE N,CLAIRE P,NOEL C.The new european regulation on pediatric medicines: Safety and ethics perspectives.Paed Drugs,2008,10(3):147-149. DAVID C.Pediatric formulations: International issues and potential solutions .Paed Drugs,2009,11(1):55-56. TONY N,JULIE W.Formulation of medicines for children.Bri J Clin Pharm,2005,59(6):674-676. YANG Z M,ZHANG P P.Analysis of the status quo and characteristics of foreign children drug review and approval management.Chin Pharm J(中国药学杂志),2012,47(10):745-748.